Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $83.00 (H.C. Wainwright)
- Lowest: $42.00 (Cantor Fitzgerald)
- Average: $63.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$63.50 (-3.1%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$63.50 (-3.1%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2024 | CapitalOne | Timothy Chiang | New Coverage | Overweight (N/A) |
N/A (N/A) |
66.05 (65.56) |
-0.74% | Details |
| 3/1/2023 | Guggenheim | Vamil Divan | New Coverage | Buy (N/A) |
55.00 (N/A) |
41.83 (65.56) |
56.73% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
